Sotera Health (NASDAQ:SHC) Trading Down 5.9% – Time to Sell?

Sotera Health Company (NASDAQ:SHC) dropped 5.9% during trading on Tuesday . The company traded as low as $14.26 and last traded at $14.4750. Approximately 1,936,603 shares were traded during mid-day trading, a decline of 23% from the average daily volume of 2,505,838 shares. The stock had previously closed at $15.39.

Wall Street Analyst Weigh In

SHC has been the topic of a number of recent research reports. Zacks Research lowered Sotera Health from a “strong-buy” rating to a “hold” rating in a research report on Friday, January 30th. Citigroup upped their target price on Sotera Health from $21.00 to $23.00 and gave the company a “buy” rating in a research report on Tuesday, February 24th. Wells Fargo & Company lowered Sotera Health to an “overweight” rating in a research report on Thursday, January 8th. Piper Sandler reiterated an “overweight” rating and issued a $22.00 target price (down from $24.00) on shares of Sotera Health in a research report on Wednesday. Finally, Barclays dropped their target price on Sotera Health from $20.00 to $18.00 and set an “overweight” rating on the stock in a research report on Tuesday, April 14th. Seven investment analysts have rated the stock with a Buy rating and three have issued a Hold rating to the stock. Based on data from MarketBeat.com, the stock currently has an average rating of “Moderate Buy” and an average target price of $20.33.

Sotera Health Price Performance

The company has a market capitalization of $4.47 billion, a price-to-earnings ratio of 38.22 and a beta of 1.82. The stock has a fifty day simple moving average of $14.94 and a 200-day simple moving average of $16.48. The company has a debt-to-equity ratio of 3.56, a current ratio of 2.82 and a quick ratio of 2.24.

Sotera Health (NASDAQ:SHC) last announced its quarterly earnings results on Tuesday, May 5th. The company reported $0.18 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $0.17 by $0.01. Sotera Health had a return on equity of 39.73% and a net margin of 9.91%.The company had revenue of $280.05 million during the quarter, compared to the consensus estimate of $270.78 million. During the same period in the previous year, the company posted $0.14 earnings per share. Sotera Health’s revenue for the quarter was up 10.0% on a year-over-year basis. Sotera Health has set its FY 2026 guidance at 0.930-1.010 EPS. On average, equities research analysts anticipate that Sotera Health Company will post 0.88 EPS for the current year.

Insider Transactions at Sotera Health

In other Sotera Health news, Director Gtcr Investment Xi Llc sold 10,000,000 shares of the business’s stock in a transaction that occurred on Friday, March 6th. The stock was sold at an average price of $15.27, for a total value of $152,700,000.00. Following the completion of the transaction, the director directly owned 12,735,301 shares of the company’s stock, valued at approximately $194,468,046.27. The trade was a 43.98% decrease in their ownership of the stock. The sale was disclosed in a legal filing with the SEC, which can be accessed through this link. Insiders own 15.36% of the company’s stock.

Institutional Inflows and Outflows

A number of large investors have recently bought and sold shares of SHC. Sculptor Capital LP lifted its holdings in Sotera Health by 57.4% in the fourth quarter. Sculptor Capital LP now owns 21,000,000 shares of the company’s stock valued at $370,440,000 after acquiring an additional 7,658,200 shares during the period. Sachem Head Capital Management LP raised its stake in shares of Sotera Health by 47.2% during the 4th quarter. Sachem Head Capital Management LP now owns 11,645,000 shares of the company’s stock worth $205,418,000 after buying an additional 3,735,000 shares during the period. Vanguard Group Inc. raised its stake in shares of Sotera Health by 16.7% during the 4th quarter. Vanguard Group Inc. now owns 19,228,375 shares of the company’s stock worth $339,189,000 after buying an additional 2,756,583 shares during the period. AQR Capital Management LLC raised its stake in shares of Sotera Health by 1,206.2% during the 4th quarter. AQR Capital Management LLC now owns 2,864,106 shares of the company’s stock worth $50,523,000 after buying an additional 2,644,831 shares during the period. Finally, Norges Bank acquired a new position in shares of Sotera Health during the 4th quarter worth approximately $45,278,000. 91.03% of the stock is owned by institutional investors and hedge funds.

About Sotera Health

Sotera Health Inc (NASDAQ: SHC) is a global provider of sterilization and laboratory testing services that support the medical device, pharmaceutical, life sciences and consumer product industries. Headquartered in Jacksonville, Florida, the company offers a suite of services designed to ensure products meet rigorous safety and regulatory requirements before reaching market.

Sotera Health operates through three primary service platforms. Its Sterigenics division delivers contract sterilization solutions, including ethylene oxide (EtO), gamma irradiation, electron beam and X-ray technologies.